Study finds breast cancer changes with spreadNovember 4th, 2009 LONDON - Almost 40 percent of breast cancer tumours change form as they spread, according to a UK study. This, according to Breakthrough Breast Cancer scientists in Edinburgh, could mean that patients require changes to their treatment regime as well.
Blood vessels could predict how prostate cancer would behaveNovember 4th, 2009 WASHINGTON - Blood vessels in prostate cancer could act as predictor of how it would behave, say researchers at The Ohio State University and the Harvard School of Public Health. The study of 572 men with localized prostate cancer indicates that aggressive or lethal prostate cancers tend to have blood vessels that are small, irregular and primitive in cross-section.
Potential new pancreatic cancer treatment safer than standard chemoNovember 3rd, 2009 WASHINGTON - Scientists from Ohio State University have designed tumour-penetrating microparticles (TPM) may offer treatment hope for those suffering with pancreatic cancer. Tiny particles can carry drugs and target cancer cells more effectively and efficiently than the standard form of chemotherapy such as those injected through a vein.
New nano-scale drug delivery system for chemotherapyNovember 2nd, 2009 LONDON - A research team led by Indian-origin scientist has developed a nano-scale drug delivery method that has been found to effectively eliminate cancer tumours after a single treatment. The Duke University study conducted over animal models revealed that after delivering the drug to the tumour, the delivery vehicle breaks down into harmless byproducts, markedly decreasing the toxicity for the recipient.
Long-term mobile phone use can 'spark tumour rise'November 1st, 2009 LONDON - A new British study suggests that the long-term use of mobile phones can create up to 1,500 cases of brain tumours per year over the next twenty years. The team led by radiation expert Dr George Carlo reviewed 23 major studies on the effects of cell phones on users to conclude that people using phones for 10 years or more had 34 percent more chances of developing brain tumours.
Turmeric can help fight cancerOctober 28th, 2009 LONDON - An extract found in the yellowish orange Indian spice turmeric can kill oesophageal cancer cells, say scientists. In the research, boffins found that when they treated oesophageal cancer cells in the laboratory with curcumin - a chemical in tumeric - it started to kill cancer cells within 24 hours.
Unilever to stop using healthy food logos while FDA develops standard criteria for labelsOctober 26th, 2009 more images
more imagesUnilever to phase out Smart Choices labelsENGLEWOOD CLIFFS, N.J. — Unilever PLC said late Monday it has decided to phase out use of the Smart Choices logo on its food and beverage products now that the Food and Drug Administration plans to standardize criteria for food nutrition labels.
Actress who played false accuser in 'To Kill a Mockingbird' dies of brain cancer in NCOctober 22nd, 2009 'To Kill a Mockingbird' actress dies in NCHIGHLANDS, N.C. — The actress who portrayed the false accuser in the movie "To Kill a Mockingbird" has died of brain cancer in North Carolina.
Hidden prostate cancer tumours evade treatment: studyOctober 9th, 2009 TORONTO - Canadian researchers have found that some hidden prostate cancer tumours cannot be diagnosed with the current procedures. Researchers at Toronto University say their findings explain why some men with elevated prostate specific antigen (PSA) levels who are carefully monitored and undergo repeated negative biopsies still develop aggressive prostate cancer.
'Dying' cancer mum beats five brain tumours to make full recoveryOctober 6th, 2009 LONDON - A woman in Britain whom doctors had said would die due to the five tumors present in her head has managed to survive. Forty-seven-year old Carole Budding of Horfield, Bristol was told that she could only live for a few weeks and was sent home by doctors from the Bristol Royal Infirmary before she made a miraculous recovery.
'Spectacular' treatment for skin cancer developedSeptember 24th, 2009 LONDON - American scientists have developed, what is being hailed as a "simply spectacular" treatment for skin cancer that could shrink the tumours at a "rapid and dramatic" rate in patients whose disease had spread. The results of the drug trial are significant because skin cancer, though curable when caught early, usually become fatal when it spreads to other parts of the body.
New drug starves tumours of blood supplySeptember 18th, 2009 WASHINGTON - A team of researchers has developed a new drug carrier that targets a tumour directly, which requires an ample supply of blood to stay alive. Ronit Satchi-Fainaro, physiologist at Tel Aviv University's (TAU) Sackler School of Medicine, and her team developed the new drug.
Scientists uncover new anti-TB compoundsSeptember 17th, 2009 LONDON - Scientists from Weill Cornell Medical College have identified certain compounds that would inhibit the sophisticated mechanism used by tuberculosis bacteria for surviving dormant in infected cells. The researchers said most of the people infected with TB remain symptom-free because the Mycobacterium tuberculosis, the disease-causing bacteria, is kept in check within immune system cells.
How salmonella can be used to kill tumoursSeptember 9th, 2009 WASHINGTON - German scientists have shown how the bacteria migrate into tumours. Sara Bartels and Siegfried Weiss, of the Helmholtz Centre for Infection Research (HZI) in Braunschweig, say that a messenger substance from the immune system makes blood vessels in the cancerous tissue permeable, and thereby enables the bacteria to conquer and destroy the tumour.
Now, a computational method to detect top genetic cancer suspectsSeptember 2nd, 2009 WASHINGTON - Johns Hopkins engineers have come up with a new computational method that can help scientists to sift through hundreds of genetic mutations to highlight the DNA changes that are most likely to promote cancer. The computational method is called CHASM, short for Cancer-specific High-throughput Annotation of Somatic Mutations.